BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27746352)

  • 1. Nanoparticles-protein interaction: Role in protein aggregation and clinical implications.
    Parveen R; Shamsi TN; Fatima S
    Int J Biol Macromol; 2017 Jan; 94(Pt A):386-395. PubMed ID: 27746352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mechanistic insight into protein-ligand interaction, folding, misfolding, aggregation and inhibition of protein aggregates: An overview.
    Chandel TI; Zaman M; Khan MV; Ali M; Rabbani G; Ishtikhar M; Khan RH
    Int J Biol Macromol; 2018 Jan; 106():1115-1129. PubMed ID: 28890370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo aspects of protein folding and quality control.
    Balchin D; Hayer-Hartl M; Hartl FU
    Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmolytes: A Possible Therapeutic Molecule for Ameliorating the Neurodegeneration Caused by Protein Misfolding and Aggregation.
    Kushwah N; Jain V; Yadav D
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31941036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of HSP70 and its co-chaperones in protein misfolding, aggregation and disease.
    Duncan EJ; Cheetham ME; Chapple JP; van der Spuy J
    Subcell Biochem; 2015; 78():243-73. PubMed ID: 25487025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and Functions of Spatial Protein Quality Control.
    Sontag EM; Samant RS; Frydman J
    Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Layers of structure and function in protein aggregation.
    Tanaka M; Komi Y
    Nat Chem Biol; 2015 Jun; 11(6):373-7. PubMed ID: 25978986
    [No Abstract]   [Full Text] [Related]  

  • 8. Nanoparticle-induced cell culture models for degenerative protein aggregation diseases.
    Chen M; von Mikecz A
    Inhal Toxicol; 2009 Jul; 21 Suppl 1():110-4. PubMed ID: 19558242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-amyloid compounds protect from silica nanoparticle-induced neurotoxicity in the nematode C. elegans.
    Scharf A; Gührs KH; von Mikecz A
    Nanotoxicology; 2016; 10(4):426-35. PubMed ID: 26444998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases.
    Soto C; Pritzkow S
    Nat Neurosci; 2018 Oct; 21(10):1332-1340. PubMed ID: 30250260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The curious cases of nanoparticle induced amyloidosis during protein corona formation and anti-amyloidogenic nanomaterials: Paradox or prejudice?
    Randhawa S; Abidi SMS; Dar AI; Acharya A
    Int J Biol Macromol; 2021 Dec; 193(Pt A):1009-1020. PubMed ID: 34728302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Methods for Structural Analysis of Protein Aggregation.
    Khan E; Mishra SK; Kumar A
    Protein Pept Lett; 2017; 24(4):331-339. PubMed ID: 28176657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-Nanoparticle Interaction-Induced Changes in Protein Structure and Aggregation.
    Kim Y; Ko SM; Nam JM
    Chem Asian J; 2016 Jul; 11(13):1869-77. PubMed ID: 27062521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
    Naeem A; Fazili NA
    Cell Biochem Biophys; 2011 Nov; 61(2):237-50. PubMed ID: 21573992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid formation characteristics of GNNQQNY from yeast prion protein Sup35 and its seeding with heterogeneous polypeptides.
    Haratake M; Takiguchi T; Masuda N; Yoshida S; Fuchigami T; Nakayama M
    Colloids Surf B Biointerfaces; 2017 Jan; 149():72-79. PubMed ID: 27736724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A health concern regarding the protein corona, aggregation and disaggregation.
    Falahati M; Attar F; Sharifi M; Haertlé T; Berret JF; Khan RH; Saboury AA
    Biochim Biophys Acta Gen Subj; 2019 May; 1863(5):971-991. PubMed ID: 30802594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein folding, misfolding and quality control: the role of molecular chaperones.
    Papsdorf K; Richter K
    Essays Biochem; 2014; 56():53-68. PubMed ID: 25131586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of biophysical and structural studies of protein self-assembly to the design of therapeutic strategies for amyloid diseases.
    Cremades N; Dobson CM
    Neurobiol Dis; 2018 Jan; 109(Pt B):178-190. PubMed ID: 28709995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural studies on the mechanism of protein aggregation in age related neurodegenerative diseases.
    Eftekharzadeh B; Hyman BT; Wegmann S
    Mech Ageing Dev; 2016 Jun; 156():1-13. PubMed ID: 27005270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When proteostasis goes bad: Protein aggregation in the cell.
    Radwan M; Wood RJ; Sui X; Hatters DM
    IUBMB Life; 2017 Feb; 69(2):49-54. PubMed ID: 28066979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.